InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II
(Q28486679)
scientific journal article
scientific journal article
Language:
Current Data About
InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||
| (P304) |
289–296
|
||||||||||||||||||||||||
| (P478) |
146 ( Pt 2)
|
||||||||||||||||||||||||
| (P577) |
Tuesday, February 1, 2000
|
||||||||||||||||||||||||
| (P921) |
(Q61476)
(Q423169) |
||||||||||||||||||||||||
| (P1433) |
(Q11339587)
|
||||||||||||||||||||||||
| (P1476) |
"InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II" (language: en)
|
||||||||||||||||||||||||
| (P2093) |
H. Marrakchi
G. Lanéelle
A. Quémard
|
||||||||||||||||||||||||
| (P2860) |
(Q22122411)
|